Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal

Jean Lud Cadet1, Subramaniam Jayanthi, Xiaolin Deng

  • 1Molecular Neuropsychiatry Branch, NIH, NIDA, Intramural Research Program, Department of Health and Human Services, 5500 Nathan Shock Dr., Baltimore, Maryland 21224, USA. jcadet@intra.nida.nih.gov

Insights

Methamphetamine (METH) causes brain damage through apoptosis, involving oxygen radicals and cell death genes. This review details METH-induced neurodegeneration mechanisms, including endoplasmic reticulum and mitochondria pathways.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Methamphetamine (METH) is a neurotoxic drug of abuse.
  • METH damages monoaminergic systems in the mammalian brain.
  • Evidence indicates METH-induced neuropathological changes occur via apoptosis.

Purpose of the Study:

  • To review the role of oxygen radicals in METH neurodegeneration.
  • To examine the involvement of transcription factors and cell death genes in METH-induced apoptosis.
  • To discuss endoplasmic reticulum and mitochondria-mediated cell death pathways.

Main Methods:

  • Review of existing scientific literature on METH neurotoxicity.
  • Analysis of studies investigating apoptotic mechanisms.
  • Discussion of gene expression profiling approaches.

Main Results:

  • METH-induced neurodegeneration involves apoptotic mechanisms.
  • Oxygen-based radicals likely participate in METH neurotoxicity.
  • Caspase-dependent and -independent cascades are activated via ER and mitochondria.

Conclusions:

  • METH triggers neuropathological changes through apoptosis.
  • Understanding METH's molecular effects requires comprehensive gene expression analysis.
  • Further research into METH's complex cellular impacts is warranted.

Related Concept Videos

Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...